NASDAQ: OSRHOsr Holdings Inc Stock
$1.38+0.00 (+0%)
Updated Apr 25, 2025
OSRH Price
$1.38
Fair Value Price
N/A
Market Cap
$26.60M
52 Week Low
$1.25
52 Week High
$13.40
P/E
-0.26x
P/B
0.18x
P/S
13.9x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.37M
Earnings
-$9.81M
Gross Margin
23%
Operating Margin
-335.42%
Profit Margin
-292.6%
Debt to Equity
0.22
Operating Cash Flow
-$2M
Beta
-0.33
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
OSRH Overview
OSR Holdings, Inc. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine OSRH's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
OSRH
Ranked#101 of 104
Ranked#101 of 104
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.65 | A | |
| $23.06 | A | |
| $14.58 | A |
Be the first to know about important OSRH news, forecast changes, insider trades & much more!
OSRH News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how OSRH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
OSRH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OSRH is good value based on its book value relative to its share price (0.18x), compared to the US Medical Devices industry average (3.92x)
P/B vs Industry Valuation
OSRH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more OSRH due diligence checks available for Premium users.
Valuation
OSRH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.26x
Industry
37.18x
Market
29.65x
OSRH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.18x
Industry
3.92x
OSRH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
OSRH's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
OSRH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
OSRH's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$179.4M
Liabilities
$32.8M
Debt to equity
0.22
OSRH's short-term liabilities ($3.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OSRH's long-term liabilities ($29.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OSRH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
OSRH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
OSRH vs Medical Device Stocks
Osr Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.